Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
GEN Review BIO 2008: Grappling with the Regulation of Biosimilars
Preserving the Incentives for Innovation Remains a Key Concern for Biotech Firms
- The vast generic pharmaceutical product market is fertile ground for litigation as companies seek to defend hard-won patent protection for their compounds in the face of fierce biogeneric competition. In the past, standards of equivalency were fairly clear, but today, with the rise of biopharmaceuticals, regulatory agencies have a ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.